Financials

  • Market Capitalization 951.69 M
  • Employee 93
  • Founded 2011
  • CEO N/A
  • Website www.annexonbio.com
  • Headquarter Delaware, United States
  • FIGI BBG007QVDFG2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.75
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2458
IMMX
Immix Biopharma, Inc. - Common Stock
13.93 USD-2.66%+1.75%+64.46%+505.65%996.54 M USD
2466
GERN
Geron Corporation - Common Stock
1.51 USD-1.31%-3.82%+4.86%+4.86%970.13 M USD
2490
ARDX
Ardelyx, Inc. - Common Stock
3.76 USD-1.57%-4.57%-25.69%-41.25%936.95 M USD
2492
DSGN
Design Therapeutics, Inc. - Common Stock
15.14 USD-0.72%-2.20%+26.80%+167.96%947.49 M USD

Notizie